Demand for MSLs and clinical education teams has risen rapidly in recent years, driven by the launch of complex, specialty medicines for chronic diseases, as well as by increased awareness of treatment options, and choice, among patients and doctors.

Advances in digital imaging technology, rising awareness in regards to screening and early diagnosis of cancer and chronic cardiovascular diseases, growing geriatric population, and increasing public awareness are further expected to fuel market growth.

The global respiratory diagnostics market is expected to grow at a CAGR of 7.1% in the first half of the forecast period.

It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the anti-inflammatory therapeutics industry.